Elvira Roda

Pamplona, NC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Development and characterization of a non-human primate model of disseminated synucleinopathy.

Development and characterization of a non-human primate model of disseminated synucleinopathy.

Journal: Frontiers in neuroanatomy

Published: December 14, 2023

Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome.

Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: May 05, 2023

Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates.

Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates.

Journal: Brain : a journal of neurology

Published: April 19, 2023

Adeno-Associated Viral Vectors as Versatile Tools for Neurological Disorders: Focus on Delivery Routes and Therapeutic Perspectives.

Adeno-Associated Viral Vectors as Versatile Tools for Neurological Disorders: Focus on Delivery Routes and Therapeutic Perspectives.

Journal: Biomedicines

Published: December 20, 2021

Adeno-Associated Viral Vectors as Versatile Tools for Parkinson's Research, Both for Disease Modeling Purposes and for Therapeutic Uses.

Adeno-Associated Viral Vectors as Versatile Tools for Parkinson's Research, Both for Disease Modeling Purposes and for Therapeutic Uses.

Journal: International journal of molecular sciences

Published: May 24, 2021

Glucocerebrosidase Gene Therapy Induces Alpha-Synuclein Clearance and Neuroprotection of Midbrain Dopaminergic Neurons in Mice and Macaques.

Glucocerebrosidase Gene Therapy Induces Alpha-Synuclein Clearance and Neuroprotection of Midbrain Dopaminergic Neurons in Mice and Macaques.

Journal: International journal of molecular sciences

Published: March 30, 2021

Expression of GPR55 and either cannabinoid CB1 or CB2 heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates.

Expression of GPR55 and either cannabinoid CB1 or CB2 heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates.

Journal: Brain structure & function

Published: March 27, 2020

Expression of cannabinoid CB1 R-GPR55 heteromers in neuronal subtypes of the Macaca fascicularis striatum.

Expression of cannabinoid CB1 R-GPR55 heteromers in neuronal subtypes of the Macaca fascicularis striatum.

Journal: Annals of the New York Academy of Sciences

Published: March 20, 2020

Glucocerebrosidase expression patterns in the non-human primate brain.

Glucocerebrosidase expression patterns in the non-human primate brain.

Journal: Brain structure & function

Published: April 28, 2017

Gene therapy approaches in the non-human primate model of Parkinson's disease.

Gene therapy approaches in the non-human primate model of Parkinson's disease.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: November 08, 2016

Neurochemical evidence supporting dopamine D1-D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulation.

Neurochemical evidence supporting dopamine D1-D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulation.

Journal: Brain structure & function

Published: June 20, 2016

Calbindin content and differential vulnerability of midbrain efferent dopaminergic neurons in macaques.

Calbindin content and differential vulnerability of midbrain efferent dopaminergic neurons in macaques.

Journal: Frontiers in neuroanatomy

Published: October 28, 2014

Showing 1-12 of 15

Last Updated: 09/26/2026